Cigna, Humana explore healthcare megamerger

Cigna (NYSE:) and tr foreign exchange Contact information of the exchange companyHumana (NYSE:) are in talks to combine in a stock-and-cash deal, the Wall Street Journal reported Wednesday afternoon citing people familiar with the matter. A deal to merge could be finalized by the end of the year, it was added.

The news sent shares of both health-insurance companies lower in mid-day trading, with Cigna last trading down 5.9% and Humana down 1.5%.

If an agreement is reached, the merged company would rival UnitedHealth Group (NYSE:) and CVS Health (NYSE:) in size.

Cigna had revenue of about $181 billion last year, while Humana posted revenue of $93 billion.

In 2015, Cigna and Humana considered merging, yet Humana opted for a deal with Aetna. However, this alliance faced antitrust issues and was blocked by a judge. Consequently, Aetna was acquired by CVS in 2018. Another attempt to merge Cigna with Anthem, rebranded as Elevance Health Inc (NYSE:), also fell through due to an unfavorable antitrust ruling.

To alleviate antitrust worries, Cigna is considering selling its current Medicare Advantage division, potentially bringing in billions through this divestment.

Statement: The content of this article does not represent the views of FTI website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!